Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -93.74% is 12% above its 5-year average of -106.86%, near the high end of its 5-year range (-279.68%–-39.07%).
As of the fiscal period ended Tuesday, June 30, 2026. 44.88% above its 12-month average of -170.06%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -93.74%.
RETURN ON INVESTED CAPITAL (ROIC)
-93.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-170.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-134.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-106.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-131.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+44.88%
CURRENT VS 3Y AVG
+30.07%
CURRENT VS 5Y AVG
+12.28%
CURRENT VS 10Y AVG
+28.88%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-162.87%
vs the sector median at left
Ocugen, Inc.
Market Cap
$352.67M
Return on Invested Capital (ROIC)
-93.74%
TTM Avg
-170.06%
3Y Avg
-134.05%
5Y Avg
-106.86%
Market Cap
$353.00M
Return on Invested Capital (ROIC)
17.99%
TTM Avg
23.20%
3Y Avg
26.35%
5Y Avg
40.47%
Market Cap
$353.88M
Return on Invested Capital (ROIC)
-24.20%
TTM Avg
-33.45%
3Y Avg
-34.14%
5Y Avg
-28.75%
Market Cap
$355.36M
Return on Invested Capital (ROIC)
11.00%
TTM Avg
8.68%
3Y Avg
7.86%
5Y Avg
11.51%
Market Cap
$355.43M
Return on Invested Capital (ROIC)
-27.16%
TTM Avg
-54.52%
3Y Avg
-49.44%
5Y Avg
-51.83%
Market Cap
$349.70M
Return on Invested Capital (ROIC)
-56.73%
TTM Avg
-80.02%
3Y Avg
-65.94%
5Y Avg
-165.76%
Market Cap
$346.73M
Return on Invested Capital (ROIC)
-84.66%
TTM Avg
-114.58%
3Y Avg
-126.88%
5Y Avg
-126.88%
Market Cap
$359.53M
Return on Invested Capital (ROIC)
-1.84%
TTM Avg
-2.07%
3Y Avg
-43.39%
5Y Avg
-53.01%
Market Cap
$344.04M
Return on Invested Capital (ROIC)
-30.78%
TTM Avg
-151.81%
3Y Avg
-134.98%
5Y Avg
-109.65%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ocugen, Inc. (OCGN) | $352.67M | -93.74% | -170.06% | -134.05% | -106.86% |
| Embecta Corp. (EMBC)vs › | $353.00M | 17.99% | 23.20% | 26.35% | 40.47% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.88M | -24.20% | -33.45% | -34.14% | -28.75% |
| Viemed Healthcare, Inc. (VMD)vs › | $355.36M | 11.00% | 8.68% | 7.86% | 11.51% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | -27.16% | -54.52% | -49.44% | -51.83% |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.70M | -56.73% | -80.02% | -65.94% | -165.76% |
| Turn Therapeutics Inc. (TTRX)vs › | $346.73M | -84.66% | -114.58% | -126.88% | -126.88% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | -1.84% | -2.07% | -43.39% | -53.01% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.04M | -30.78% | -151.81% | -134.98% | -109.65% |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | -59.29% | -166.84% | -79.03% | -92.27% |
ROIC
-93.7%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -93.74% |
| 2026-03-31 | -160.80% |
| 2025-12-31 | -279.68% |
| 2025-09-30 | -160.50% |
| 2025-06-30 | -155.56% |
| 2025-03-31 | -119.90% |
| 2024-12-31 | -88.06% |
| 2024-09-30 | -104.32% |
| 2024-06-30 | -204.05% |
| 2024-03-31 | -153.37% |
| 2023-12-31 | -131.97% |
| 2023-09-30 | -120.56% |
| 2023-06-30 | -115.71% |
| 2023-03-31 | -103.66% |
| 2022-12-31 | -105.95% |
| 2022-09-30 | -74.30% |
| 2022-06-30 | -52.58% |
| 2022-03-31 | -51.48% |
| 2021-12-31 | -58.76% |
| 2021-09-30 | -42.93% |
| 2021-06-30 | -39.07% |
| 2021-03-31 | -48.88% |
| 2020-12-31 | -88.70% |
| 2020-09-30 | -123.48% |
| 2020-06-30 | -68.74% |
| 2020-03-31 | -155.38% |
| 2019-12-31 | -147.63% |
| 2019-06-30 | -1155.75% |
| 2019-03-31 | -235.11% |
| 2018-12-31 | -206.86% |
| 2018-09-30 | -1362.18% |
| 2018-06-30 | -719.03% |
| 2018-03-31 | -186.97% |
| 2017-12-31 | -336.80% |
| 2017-09-30 | -202.62% |
| 2017-06-30 | -147.88% |
| 2017-03-31 | -117.43% |
| 2016-12-31 | -96.24% |
| 2016-09-30 | -84.92% |
| 2016-06-30 | -212.06% |
| 2016-03-31 | -137.28% |
| 2015-12-31 | -102.61% |
| 2015-09-30 | -76.65% |
| 2015-06-30 | -78.38% |
| 2015-03-31 | -64.74% |
| 2014-12-31 | -56.65% |
| 2014-09-30 | -574.65% |
| 2014-06-30 | -239.10% |
